Bempedoic acid is primarily used in the management of hypercholesterolemia, particularly in patients who require additional lipid-lowering therapy beyond statins. It works by inhibiting ATP citrate lyase, an enzyme involved in cholesterol synthesis in the liver, thereby reducing LDL cholesterol levels. This makes it a valuable option for individuals with familial hypercholesterolemia or those at high risk for cardiovascular events who cannot achieve target LDL levels with statins alone. It is often prescribed in combination with other lipid-lowering agents to enhance efficacy. Additionally, bempedoic acid is beneficial for patients who are statin-intolerant, offering an alternative to manage cholesterol levels effectively. Its oral administration and once-daily dosing improve patient compliance, making it a practical choice for long-term therapy.